Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET

Company Participants

Matt Scalo - Senior Vice President-Investor Relations
Paul Diaz - President & Chief Executive Officer
Mark Verratti - Chief Commercial Officer
Sam Raha - Chief Operating Officer
Scott Leffler - Chief Financial Officer

Conference Call Participants

Matt Sykes - Goldman Sachs
Colleen Babington - Wolfe Research
Andrew Cooper - Raymond James
Casey Woodring - JPMorgan
Puneet Souda - Leerink Partners
Kyle Boucher - TD Cowen

Operator

Good day, and thank you for standing by. Welcome to the Myriad Genetics Second Quarter 2024 Financial Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker Matt Scalo, Senior Vice President of Investor Relations. Please go ahead.

Matt Scalo

Thanks, Gerald and good afternoon and welcome to the Myriad Genetics second quarter 2024 earnings call. During the call, we will review the financial results we released today and afterwards we will host a question-and-answer session. Our quarterly earnings release was issued this afternoon on Form 8-K and can be found on our website at investor.myriad.com.

I'm Matt Scalo, Senior Vice President of Investor Relations and on the call with me today are Paul Diaz, our President and Chief Executive Officer; Scott Leffler, our Chief Financial Officer; Sam Raha, our Chief Operating Officer; and Mark Verratti, our Chief Commercial Officer. This call can be heard live via webcast at investor.myriad.com and a recording will be archived in the Investors section of our website along with this slide presentation.

Please note that some of the information presented today contains projections or other forward-looking statements regarding future events or the future financial performance of the company. These statements are based on management’s current expectations, and the actual events or results may differ materially and adversely from these expectations for a variety of reasons. We refer you to the documents the company files from time to time with the SEC, specifically the company’s annual report on Form 10-K, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. These documents identify important risk factors that could cause the actual result to different materially from those contained in our projections or forward-looking statements.